Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Use this TRDA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TRDA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TRDA SEC filings page. Lician reads the product cache first so this HTML stays unique to Entrada Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TRDA income, balance, and cash tables.